A detailed history of Pine Bridge Investments, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 142,396 shares of LLY stock, worth $107 Million. This represents 0.97% of its overall portfolio holdings.

Number of Shares
142,396
Previous 116,947 21.76%
Holding current value
$107 Million
Previous $106 Million 19.15%
% of portfolio
0.97%
Previous 0.87%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $19.7 Million - $24.4 Million
25,449 Added 21.76%
142,396 $126 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $41 Million - $51.5 Million
-56,607 Reduced 32.62%
116,947 $106 Million
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $24.9 Million - $33.4 Million
42,127 Added 32.05%
173,554 $135 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $11.1 Million - $13.1 Million
21,157 Added 19.19%
131,427 $76.6 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $18.8 Million - $25.9 Million
43,227 Added 64.48%
110,270 $59.2 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $1.67 Million - $2.23 Million
4,750 Added 7.63%
67,043 $31.4 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $779,060 - $914,968
2,508 Added 4.2%
62,293 $21.4 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $4.07 Million - $4.75 Million
-12,666 Reduced 17.48%
59,785 $21.9 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $3.55 Million - $4.04 Million
-11,972 Reduced 14.18%
72,451 $23.4 Million
Q2 2022

Aug 05, 2022

SELL
$278.73 - $327.27 $1.04 Million - $1.22 Million
-3,717 Reduced 4.22%
84,423 $27.4 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $1.32 Million - $1.65 Million
5,644 Added 6.84%
88,140 $25.2 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $1.66 Million - $2.06 Million
7,380 Added 9.82%
82,496 $22.8 Million
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $162,432 - $199,896
-733 Reduced 0.97%
75,116 $17.4 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $1.83 Million - $2.37 Million
10,156 Added 15.46%
75,849 $17.4 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $2.54 Million - $3.28 Million
-15,441 Reduced 19.03%
65,693 $12.3 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $2.25 Million - $2.98 Million
-17,238 Reduced 17.52%
81,134 $13.7 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $5.26 Million - $6.08 Million
35,978 Added 57.66%
98,372 $14.6 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $8.31 Million - $10 Million
60,894 Added 4059.6%
62,394 $10.2 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $17.8 Million - $22 Million
-149,184 Reduced 99.0%
1,500 $208,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $1.41 Million - $1.75 Million
-13,213 Reduced 8.06%
150,684 $19.8 Million
Q3 2019

Nov 13, 2019

BUY
$106.79 - $116.16 $6.49 Million - $7.06 Million
60,817 Added 59.0%
163,897 $18.3 Million
Q2 2019

Aug 13, 2019

BUY
$110.79 - $129.32 $11.4 Million - $13.3 Million
103,080 New
103,080 $11.4 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $52,315 - $61,579
-470 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$105.9 - $118.64 $49,773 - $55,760
470 New
470 $54,000
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $1.17 Million - $1.46 Million
-13,643 Closed
0 $0
Q2 2018

Aug 09, 2018

SELL
$75.7 - $86.88 $21.1 Million - $24.2 Million
-278,078 Reduced 95.32%
13,643 $1.16 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $6.32 Million - $7.46 Million
85,192 Added 41.25%
291,721 $22.6 Million
Q4 2017

Feb 09, 2018

BUY
$81.94 - $87.89 $6.14 Million - $6.59 Million
74,985 Added 57.0%
206,529 $17.4 Million
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $3.21 Million - $3.56 Million
41,603 Added 46.26%
131,544 $11.3 Million
Q2 2017

Aug 11, 2017

BUY
N/A
89,941
89,941 $7.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.